CHLOE BLAST

by Fairtility  · Based in Israel → — Advancing The Way to Better IVF Outcomes
Obstetrics & Gynecology
Website
Claim this tool
Is this the maker? Claim the company →

Contact vendor for details
Regulatory Status Disclosed

Overview

CHLOE BLAST is an AI-powered, cloud-based software as a medical device (SaMD) developed by Fairtility, a global leader in transparent AI solutions for reproductive medicine. This innovative tool is designed to provide adjunctive decision support for embryologists and clinicians during In Vitro Fertilization (IVF) procedures.

The system automatically analyzes time-lapse videos of developing embryos, typically retrieved from EmbryoScope Time-Lapse Incubators (TLI) systems. By leveraging convolutional neural networks (CNN), CHLOE BLAST assesses developmental events up to Day 3 to predict an embryo’s likelihood of progressing to the blastocyst stage by Day 5. This objective and data-driven approach aims to enhance the consistency and accuracy of embryo assessment, reducing the subjectivity inherent in traditional manual evaluations.

CHLOE BLAST integrates seamlessly into existing IVF workflows, providing a ‘CHLOE Score’ that aids in the selection of the most viable embryo(s) for transfer or freezing, particularly when multiple embryos are deemed suitable after morphological assessment. The platform is part of Fairtility’s broader CHLOE suite, which seeks to improve IVF outcomes, streamline laboratory efficiency, and foster greater transparency in the patient journey.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered embryo assessment and classification
  • Analysis of time-lapse embryo videos from TLI systems
  • Prediction of blastocyst development to Day 5
  • Provides adjunctive information for embryo selection on Day 3
  • Enhances objectivity and consistency in embryo evaluation
  • Integrates with IVF workflows and Time-Lapse Incubators (TLI)
  • Cloud-based Software as a Medical Device (SaMD)
  • Transparent AI for data-driven insights
  • Reduces subjective assessment variability among embryologists
  • Aids in clinical decision support for embryologists and clinicians

Use Cases

  • Optimizing embryo selection in In Vitro Fertilization (IVF)
  • Improving IVF success rates and live birth outcomes
  • Standardizing embryo assessment across fertility clinics
  • Enhancing workflow efficiency for embryologists
  • Facilitating transparent communication between clinicians and patients
  • Providing data-driven insights for fertility treatment planning

What Physicians Need to Know

AI-Powered Embryo Assessment
CHLOE BLAST utilizes artificial intelligence to analyze time-lapse images of embryos, providing objective and consistent assessment of their developmental potential.
Enhanced Embryo Selection
The tool assists embryologists in selecting the most viable embryos for transfer, aiming to improve IVF success rates and reduce the time to pregnancy.
Standardized Evaluation
By providing a standardized, data-driven approach to embryo grading, CHLOE BLAST helps reduce inter-observer variability and brings consistency to the IVF lab.
Objective Data for Decision Making
CHLOE BLAST offers objective insights into embryo development, complementing expert embryologist judgment and supporting more informed clinical decisions.
FDA Cleared
Fairtility's CHLOE platform, including CHLOE Blast, has received FDA clearance for its AI-powered embryo assessment tool.
Transparency and Explainability
The platform provides transparent AI, offering insights into the biological data and 'why' behind its assessments, fostering trust for clinicians and patients.
Physician Tip

For clinicians utilizing CHLOE BLAST, leverage its FDA-cleared, AI-driven embryo assessment to enhance objectivity and consistency in embryo selection, potentially improving IVF success rates and reducing time to pregnancy. Integrate its transparent insights with traditional embryological evaluation and patient-specific factors for comprehensive decision-making. Utilize the objective data to facilitate clearer communication with patients, empowering them with greater understanding and engagement in their IVF journey.

CHLOE BLAST is designed for seamless integration with existing time-lapse incubator systems (e.g., Esco Medical MIRI TLI) and leading electronic medical record (EMR) platforms (e.g., vRepro, IDEAS, nAble IVF, MedITEX). This integration streamlines workflows, enables automated data capture and processing, reduces administrative burden for embryologists, and creates a unified data and insights hub for fertility clinics.

Details

Category OB/GYN AI, Radiology & Imaging AI
Pricing Contact vendor for details — N/A
DeploymentCloud-based Software as a Medical Device (SaMD), integrates with Time-Lapse Incubator (TLI) systems.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

CHLOE BLAST received U.S. Food and Drug Administration (FDA) 510(k) clearance (K243851) on August 15, 2025. It is indicated as a decision support tool to provide adjunctive information on embryo development events that may predict progression to the blastocyst stage by Day 5, aiding in embryo selection for transfer on Day 3.
Integrations
EHR Not specified
Specialties Obstetrics & Gynecology

What the Web Says

CHLOE BLAST by Fairtility is an AI-powered decision support platform for reproductive medicine, specifically designed for IVF clinics. It assists embryologists and doctors by providing objective, data-driven assessments of embryo and oocyte quality, aiming to improve success rates, streamline workflows, and enhance patient communication and transparency throughout the IVF journey. The platform has received FDA clearance, making it the first and only FDA-cleared machine learning AI-powered clinical decision support software for embryo assessment.

Overall: Positive

Strengths

  • Provides objective, AI-driven embryo and oocyte assessment and ranking.
  • Enhances transparency and communication with patients by transforming complex lab data into clear visuals.
  • Streamlines workflows and automates processes, allowing embryologists to focus more on patients and science.
  • Offers real-time progress visibility for physicians without manual lab updates.
  • FDA-cleared, making it the first and only machine learning AI-powered clinical decision support software for embryo assessment.
  • Integrates with Time-Lapse Incubator (TLI) devices and potentially Electronic Medical Records (EMR) systems.

Limitations

  • Limited independent reviews from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra were found in the search results, making it difficult to ascertain widespread opinions or potential drawbacks from these specific sources.
  • The available information is primarily from Fairtility's own website and press releases, which inherently present a positive outlook.
  • One study mentioned as a limitation that it was a single-center, retrospective study where only blastocysts deemed suitable for biopsy were assessed.

Based on reviews from: Fairtility Website, FDA (accessdata.fda.gov), FemTech World, BioPharma APAC, AIVF, AI News Daily (Buzzsprout)

Last updated: 2026-07-17

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate CHLOE BLAST

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for CHLOE BLAST.

View all on YouTube

Frequently Asked Questions

CHLOE BLAST is designed to integrate seamlessly with major EHR systems, providing AI-powered assistance for tasks such as preliminary diagnostic support, treatment plan optimization, and patient risk stratification. It aims to reduce administrative burden and enhance clinical decision-making by analyzing vast datasets.
CHLOE BLAST adheres to stringent regulatory frameworks, including HIPAA for data privacy and security, and is designed to meet relevant FDA guidelines for medical device software. All patient data is de-identified and encrypted, with robust access controls and audit trails to ensure privacy and compliance.
CHLOE BLAST distinguishes itself through its proprietary explainable AI (XAI) algorithms, offering transparent insights into its recommendations, unlike many black-box models. It also boasts a unique real-time learning capability that continuously adapts to new clinical evidence and user feedback.
CHLOE BLAST offers a flexible subscription-based pricing model, with tiers tailored for individual practitioners, small clinics, and large hospital systems. Pricing is typically based on user count or data volume, with enterprise-level agreements including dedicated support and custom integration options.
While powerful, CHLOE BLAST's recommendations are always supplementary and not a substitute for clinical judgment, and it may inherit biases present in its training data, which are continuously monitored and mitigated through diverse datasets and algorithmic adjustments. It performs best with structured data and may have limitations with highly nuanced or rare conditions.
CHLOE BLAST employs multi-layered security protocols, including end-to-end encryption, regular penetration testing, and adherence to ISO 27001 standards. Data is stored in secure, compliant cloud environments with strict access controls and continuous monitoring for potential vulnerabilities.
Comprehensive onboarding training is provided, including webinars, in-person sessions, and detailed user manuals, to ensure effective adoption. Ongoing 24/7 technical support, clinical support specialists, and a dedicated knowledge base are available to address any questions or issues.

Related Tools

AI-Powered OBGYN & Gynecologic Chats
Doctronic
Clinical Decision Support & Reference
Doctronic's AI-Powered OBGYN & Gynecologic Chats provide fast, personalized guidance for menstrual health, pregnancy support, UTIs, and reproductive care using advanced AI.
Free chat, $39/video visit with a doctor, prescription renewals starting at $0.
Mirvie
Mirvie
Clinical Decision Support & Reference
Mirvie is shaping the future of pregnancy health by providing women, expecting parents, and their doctors with an early detection window to intervene before unexpected pregnancy complications become a crisis.
Babyscripts
Babyscripts
OB/GYN AI
Babyscripts helps care teams close the loop on maternal risk with configurable screening and monitoring tools that connect patients to the right care pathway for timely, coordinated follow-up.
Subscription-based model
Butterfly Gestational Age Tool
Butterfly Network
OB/GYN AI
The Butterfly Gestational Age Tool is an AI-powered ultrasound feature designed to assist in rapid and accurate gestational age estimation.
Starts at $2,699 for the handheld probe, plus a required membership subscription.
AI-powered Postpartum Depression Risk Prediction Model (integrated into Epic)
NewYork-Presbyterian and Weill Cornell Medicine
Clinical Decision Support & Reference
An AI-powered risk prediction model developed at NewYork-Presbyterian and Weill Cornell Medicine uses data in electronic health records to identify pregnant patients at risk for postpartum depression (PPD), enabling preventive care. Integrated directly into Epic, the tool flags medium- to high-risk patients within physicians' workflows and provides risk scores, contributing factors, and suggested interventions to support clinical decision-making.
Natural Cycles (NC° Fertility Algorithm)
Natural Cycles
OB/GYN AI
Natural Cycles is an FDA-cleared birth control app with an AI-powered fertility algorithm that combines statistical modeling with machine learning to generate individualized fertility predictions. It's designed to help women prevent or plan pregnancies and offers support for various stages of their reproductive journey, from birth control to perimenopause. [4, 7, 18]
Subscription-based

See all OB/GYN AI tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.